Literature DB >> 23219166

Socioeconomic inequalities in drug utilization for Sweden: evidence from linked survey and register data.

Martin Nordin1, Margareta Dackehag, Ulf-G Gerdtham.   

Abstract

This study analyzes the socioeconomic gradient in drug utilization. We use The Swedish Prescribed Drug Register, merged with the Survey of Living Conditions (the ULF), and the study sample consists of 8138 individuals. We find a positive education gradient (but no income gradient) in drug utilization, after controlling for health indicators. Whereas high-educated men use a larger number of drugs, high-educated women use both a larger number of drugs and more expensive drugs. For males, but not as clearly for females, we find that the education gradient is weaker for more health-related drugs but stronger for more expensive drugs. We conclude that the main reason for the education gradient in drug utilization is doctors' behaviour rather than compliance with medication and affordability of drugs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23219166     DOI: 10.1016/j.socscimed.2012.11.013

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  17 in total

1.  Recommended drug use after acute myocardial infarction by migration status and education level.

Authors:  Dashti Ali Mustafa Dzayee; Tahereh Moradi; Omid Beiki; Lars Alfredsson; Rickard Ljung
Journal:  Eur J Clin Pharmacol       Date:  2015-02-28       Impact factor: 2.953

2.  Big Data: Will It Improve Patient-Centered Care?

Authors:  Denzil G Fiebig
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

3.  Socio-economic and behavioral determinants of prescription and non-prescription medicine use: the case of Turkey.

Authors:  Selcen Öztürk; Dilek Başar; İlhan Can Özen; Arbay Özden Çiftçi
Journal:  Daru       Date:  2019-11-16       Impact factor: 3.117

4.  Financial crisis and income-related inequalities in the universal provision of a public service: the case of healthcare in Spain.

Authors:  Ignacio Abásolo; Marc Saez; Guillem López-Casasnovas
Journal:  Int J Equity Health       Date:  2017-07-24

5.  Are There Inequities in Treatment of End-Stage Renal Disease in Sweden? A Longitudinal Register-Based Study on Socioeconomic Status-Related Access to Kidney Transplantation.

Authors:  Ye Zhang; Johan Jarl; Ulf-G Gerdtham
Journal:  Int J Environ Res Public Health       Date:  2017-01-27       Impact factor: 3.390

6.  Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries.

Authors:  Sabine Vogler; August Österle; Susanne Mayer
Journal:  Int J Equity Health       Date:  2015-11-05

7.  Asthma incidence in children growing up close to traffic: a registry-based birth cohort.

Authors:  Anna Lindgren; Emilie Stroh; Jonas Björk; Kristina Jakobsson
Journal:  Environ Health       Date:  2013-10-26       Impact factor: 5.984

8.  Treatment pattern of type 2 diabetes differs in two German regions and with patients' socioeconomic position.

Authors:  Teresa Tamayo; Heiner Claessen; Ina-Maria Rückert; Werner Maier; Michaela Schunk; Christine Meisinger; Andreas Mielck; Rolf Holle; Barbara Thorand; Maria Narres; Susanne Moebus; Amir-Abbas Mahabadi; Noreen Pundt; Bastian Krone; Uta Slomiany; Raimund Erbel; Karl-Heinz Jöckel; Wolfgang Rathmann; Andrea Icks
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

9.  Investigation of social, demographic and health variations in the usage of prescribed and over-the-counter medicines within a large cohort (South Yorkshire, UK).

Authors:  Mark A Green; Emma Little; Richard Cooper; Clare Relton; Mark Strong
Journal:  BMJ Open       Date:  2016-09-28       Impact factor: 2.692

10.  Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden.

Authors:  Pernilla J Bjerkeli; Shai Mulinari; Sofia Zettermark; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2017-11-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.